Nonmetastatic Osteosarcoma
Showing 1 - 25 of 259
Observational Study in Localized Osteosarcoma
Active, not recruiting
- Localized Osteosarcoma
- Treatment of Osteosarcoma according the AIEOP/ISG OS 2021 recommendations (includes drugs, surgery, radiotherapy or any other received treatments)
-
Aviano, Pordenone, Italy
- +15 more
Oct 29, 2021
Quality of Life of Bone Tumor of Lower Limbs Treated With
Enrolling by invitation
- Sarcoma, Ewing
- +2 more
-
Bologna, ItalyIstituto Ortopedico Rizzoli
Mar 17, 2023
Osteosarcoma of Pelvis Trial in Beijing (drug, procedure, other)
Recruiting
- Osteosarcoma of Pelvis
- Doxorubicin
- +5 more
-
Beijing, Beijing, ChinaPeking University People's Hospital
Aug 25, 2018
Osteosarcoma Trial in France (Mifamurtide, EI or M-API regimen depending on patient age)
Recruiting
- Osteosarcoma
- Mifamurtide
- EI or M-API regimen depending on patient age
-
Amiens, France
- +30 more
Dec 8, 2022
Local Relapse After High Grade Osteosarcoma
Recruiting
- Osteosarcoma
-
Bologna, BO, Italy
- +1 more
Aug 24, 2023
Soluble B7-H3 as a Biomarker for Osteosarcoma
Recruiting
- Biomarker
- +3 more
- ELISA: enzyme-linked immunosorbent assay
-
Beijing, Beijing, ChinaPeking University People's Hospital
Jul 5, 2023
3D Printed Personalized Extendable Prosthesis
Completed
- Osteosarcoma in Children
- 3D printed personalized extendable prosthesis
-
Chongqing, Chongqing, ChinaChildren's Hospital of Chongqing Medical University
Mar 30, 2023
Ewing Sarcoma, Ewing Sarcoma of Bone, Ewing Sarcoma of Soft Tissue Trial in United States (FoundationOne Liquid CDx)
Recruiting
- Ewing Sarcoma
- +6 more
- FoundationOne Liquid CDx
-
Los Angeles, California
- +14 more
Oct 5, 2023
An Organoid-based Functional Precision Medicine Trial in
Not yet recruiting
- Osteosarcoma
- standard of care biopsy
- (no location specified)
Sep 26, 2023
Construction of Microfluidic Exosome Chip for Diagnosis of Lung
Completed
- Osteosarcoma
- Pulmonary Metastases
-
Shanghai, Shanghai, ChinaRuijin Hospital Shanghai Jiao Tong University School of Medicine
Nov 14, 2022
Osteosarcoma Trial (Surufatinib plus chemo, Chemotherapy)
Not yet recruiting
- Osteosarcoma
- Surufatinib plus chemotherapy
- Chemotherapy
- (no location specified)
Jun 29, 2023
Osteosarcoma Trial (Tucidinostat, Apatinib)
Not yet recruiting
- Osteosarcoma
- Tucidinostat, Apatinib
- (no location specified)
Nov 5, 2023
Cholangiocarcinoma Trial in Navi Mumbai (High Dose Radiation, Systemic chemo)
Recruiting
- Cholangiocarcinoma
- High Dose Radiation
- Systemic chemotherapy
-
Navi Mumbai, Maharashtra, IndiaAdvanced Centre of Treatment Research and Education In Cancer,Ta
Oct 20, 2022
Chemotherapy on Fertility in Osteosarcoma Survivors
Active, not recruiting
- Osteosarcoma
- Biospecimen Collection
- +2 more
-
Birmingham, Alabama
- +98 more
Oct 19, 2022
Osteosarcoma, Osteosarcoma in Children, Osteosarcoma Recurrent Trial in United States (Regorafenib 40 MG, Regorafenib 20MG,
Recruiting
- Osteosarcoma
- +3 more
- Regorafenib 40 MG
- +2 more
-
Los Angeles, California
- +7 more
Jan 19, 2023
Osteosarcoma, Soft Tissue Sarcoma Trial in Shanghai (NK510)
Recruiting
- Osteosarcoma
- Soft Tissue Sarcoma
-
Shanghai, ChinaShanghai General Hospital
Oct 31, 2023
Osteosarcoma Trial in United States (Avelumab, Questionnaires)
Active, not recruiting
- Osteosarcoma
- Avelumab
- Questionnaires
-
Los Angeles, California
- +3 more
Aug 22, 2022
Osteosarcoma Trial in Shanghai (metastasectomy and pre-operative immunotherapy (gemcitabine and penpulimab ) and stereotactic
Recruiting
- Osteosarcoma
- metastasectomy and pre-operative immunotherapy (gemcitabine and penpulimab ) and stereotactic body radiotherapy
-
Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai Jiao Tong University, School of Medici
Nov 1, 2023
SBRT, Borderline Resectable Pancreatic Cancer, Unresectable Pancreatic Cancer Trial in Worldwide (Drug GC4711, Placebo)
Recruiting
- SBRT
- +2 more
- Drug GC4711
- Placebo
-
Gilbert, Arizona
- +23 more
Aug 12, 2022
Patients With Osteosarcoma
Not yet recruiting
- Osteosarcoma
- (no location specified)
Sep 6, 2022
Osteogenic Sarcoma Recurrent Trial in Hackensack, Houston (Iscador*P)
Not yet recruiting
- Osteogenic Sarcoma Recurrent
-
Hackensack, New Jersey
- +1 more
Feb 3, 2023
Advanced Renal Cell Carcinoma, Advanced Mesothelioma, Advanced Osteosarcoma Trial in Houston (CAR.70/IL15-transduced CB-derived
Not yet recruiting
- Advanced Renal Cell Carcinoma
- +2 more
- CAR.70/IL15-transduced CB-derived NK cells
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 27, 2023
Osteosarcoma Metastatic, Ewing's Sarcoma Metastatic Trial in Miami (Chemotherapy (gemcitabine & docetaxel) plus BIO-11006)
Active, not recruiting
- Osteosarcoma Metastatic
- Ewing's Sarcoma Metastatic
- Chemotherapy (gemcitabine & docetaxel) plus BIO-11006
-
Miami, FloridaNicklaus Children's Hospital
Nov 8, 2022
High Risk Neuroblastoma, Recurrent Neuroblastoma, Recurrent Osteosarcoma Trial in Canada, United States (Dinutuximab,
Recruiting
- High Risk Neuroblastoma
- +4 more
- Biospecimen Collection
- +6 more
-
Los Angeles, California
- +10 more
Jan 19, 2023